Liu JO - Search Results

1

Large-scale phenotypic drug screen identifies neuroprotectants in zebrafish and mouse models of retinitis pigmentosa.

Zhang L, Chen C, Fu J, Lilley B, Berlinicke C, Hansen B, Ding D, Wang G, Wang T, Shou D, Ye Y, Mulligan T, Emmerich K, Saxena MT, Hall KR, Sharrock AV, Brandon C, Park H, Kam TI, Dawson VL, Dawson TM, Shim JS, Hanes J, Ji H, Liu JO, Qian J, Ackerley DF, Rohrer B, Zack DJ, Mumm JS. Zhang L, et al. Among authors: liu jo. Elife. 2021 Jun 29;10:e57245. doi: 10.7554/eLife.57245. Elife. 2021. PMID: 34184634 Free PMC article.

2

First quantitative high-throughput screen in zebrafish identifies novel pathways for increasing pancreatic β-cell mass.

Wang G, Rajpurohit SK, Delaspre F, Walker SL, White DT, Ceasrine A, Kuruvilla R, Li RJ, Shim JS, Liu JO, Parsons MJ, Mumm JS. Wang G, et al. Among authors: liu jo. Elife. 2015 Jul 28;4:e08261. doi: 10.7554/eLife.08261. Elife. 2015. PMID: 26218223 Free PMC article.

3

Chemical screen identifies FDA-approved drugs and target pathways that induce precocious pancreatic endocrine differentiation.

Rovira M, Huang W, Yusuff S, Shim JS, Ferrante AA, Liu JO, Parsons MJ. Rovira M, et al. Among authors: liu jo. Proc Natl Acad Sci U S A. 2011 Nov 29;108(48):19264-9. doi: 10.1073/pnas.1113081108. Epub 2011 Nov 14. Proc Natl Acad Sci U S A. 2011. PMID: 22084084 Free PMC article.

4

Tricyclic thiazoles are a new class of angiogenesis inhibitors.

Bhat S, Shim JS, Liu JO. Bhat S, et al. Among authors: liu jo. Bioorg Med Chem Lett. 2013 May 1;23(9):2733-7. doi: 10.1016/j.bmcl.2013.02.067. Epub 2013 Feb 24. Bioorg Med Chem Lett. 2013. PMID: 23518276 Free PMC article.

5

Recent advances in drug repositioning for the discovery of new anticancer drugs.

Shim JS, Liu JO. Shim JS, et al. Among authors: liu jo. Int J Biol Sci. 2014 Jun 10;10(7):654-63. doi: 10.7150/ijbs.9224. eCollection 2014. Int J Biol Sci. 2014. PMID: 25013375 Free PMC article. Review.

6

PAAN/MIF nuclease inhibition prevents neurodegeneration in Parkinson's disease.

Park H, Kam TI, Peng H, Chou SC, Mehrabani-Tabari AA, Song JJ, Yin X, Karuppagounder SS, Umanah GK, Rao AVS, Choi Y, Aggarwal A, Chang S, Kim H, Byun J, Liu JO, Dawson TM, Dawson VL. Park H, et al. Among authors: liu jo. Cell. 2022 May 26;185(11):1943-1959.e21. doi: 10.1016/j.cell.2022.04.020. Epub 2022 May 10. Cell. 2022. PMID: 35545089 Free PMC article.

7

Sanglifehrin A, a novel cyclophilin-binding immunosuppressant, inhibits IL-2-dependent T cell proliferation at the G1 phase of the cell cycle.

Zhang LH, Liu JO. Zhang LH, et al. Among authors: liu jo. J Immunol. 2001 May 1;166(9):5611-8. doi: 10.4049/jimmunol.166.9.5611. J Immunol. 2001. PMID: 11313401

8

Efficient drug screening and gene correction for treating liver disease using patient-specific stem cells.

Choi SM, Kim Y, Shim JS, Park JT, Wang RH, Leach SD, Liu JO, Deng C, Ye Z, Jang YY. Choi SM, et al. Among authors: liu jo. Hepatology. 2013 Jun;57(6):2458-68. doi: 10.1002/hep.26237. Hepatology. 2013. PMID: 23325555 Free PMC article.

9

Inhibition of cell cycle progression by the novel cyclophilin ligand sanglifehrin A is mediated through the NFkappa B-dependent activation of p53.

Zhang LH, Youn HD, Liu JO. Zhang LH, et al. Among authors: liu jo. J Biol Chem. 2001 Nov 23;276(47):43534-40. doi: 10.1074/jbc.M104257200. Epub 2001 Sep 13. J Biol Chem. 2001. PMID: 11557753 Free article.

10

Substituted oxines inhibit endothelial cell proliferation and angiogenesis.

Bhat S, Shim JS, Zhang F, Chong CR, Liu JO. Bhat S, et al. Among authors: liu jo. Org Biomol Chem. 2012 Apr 21;10(15):2979-92. doi: 10.1039/c2ob06978d. Epub 2012 Mar 6. Org Biomol Chem. 2012. PMID: 22391578 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

211 results

Search Page